Panteghini Mauro
Department of Laboratory Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland.
Clin Chem Lab Med. 2024 Nov 26;63(5):916-922. doi: 10.1515/cclm-2024-1208. Print 2025 Apr 28.
Although the concept of bias appears consolidated in laboratory science, some important changes in its definition and management have occurred since the introduction of metrological traceability theory in laboratory medicine. In the traceability era, medical laboratories should rely on manufacturers who must ensure traceability of their diagnostic medical devices (IVD-MD) to the highest available references, providing bias correction during the trueness transfer process to calibrators before they are marketed. However, sometimes some bias can be observed arising from an insufficient correction during the traceability implementation. This source of bias can be discovered by the IVD-MD surveillance by traceability-based external quality assessment and confirmed by validation experiments. The assessment of significance should be based on its impact on measurement uncertainty (MU) of results. The IVD manufacturer, appropriately warned, is responsible to take an immediate investigation and eventually fix the problem with a corrective action. Even if IVD-MD is correctly aligned in the validation steps and bias components are eliminated, during ordinary use the system may undergo systematic variations such as those caused by recalibrations and lot changes. These sources of randomly occurring bias are incorporated in the estimate of intermediate reproducibility of IVD-MD through internal quality control and can be tolerated until the estimated MU on clinical samples fulfils the predefined specifications. A readjustment of the IVD-MD by the end-user must be undertaken to try to correct the bias becoming significant. If the bias remains, the IVD manufacturer should be requested to rectify the problem.
尽管偏差的概念在实验室科学中似乎已得到巩固,但自计量溯源理论引入检验医学以来,其定义和管理发生了一些重要变化。在溯源时代,医学实验室应依赖制造商,制造商必须确保其诊断医疗设备(IVD-MD)可溯源至最高可用参考标准,并在校准品上市前的溯源性传递过程中进行偏差校正。然而,有时在溯源实施过程中可能会观察到由于校正不足而产生的一些偏差。这种偏差来源可通过基于溯源的外部质量评估对IVD-MD进行监测发现,并通过验证实验加以确认。对其显著性的评估应基于其对结果测量不确定度(MU)的影响。IVD制造商在得到适当警告后,有责任立即进行调查,并最终采取纠正措施解决问题。即使IVD-MD在验证步骤中校准正确且偏差分量已消除,但在日常使用中,系统仍可能出现系统变化,如重新校准和批次更换所导致的变化。这些随机出现的偏差来源通过内部质量控制纳入IVD-MD中间精密度的估计中,并且在临床样本的估计MU满足预定义规范之前可以容忍。最终用户必须对IVD-MD进行调整,以尝试校正变得显著的偏差。如果偏差仍然存在,应要求IVD制造商解决该问题。